Log in to save to my catalogue

Clearance of Driver Mutations after Transplantation for Myelofibrosis

Clearance of Driver Mutations after Transplantation for Myelofibrosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153879153

Clearance of Driver Mutations after Transplantation for Myelofibrosis

About this item

Full title

Clearance of Driver Mutations after Transplantation for Myelofibrosis

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2025-01, Vol.392 (2), p.150-160

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for myelofibrosis. Driver mutations are the pathophysiological hallmark of the disease, but the role of mutation clearance after transplantation is unclear.
We used highly sensitive polymerase-chain-reaction technology to analyze the dynamics of driver mutations in...

Alternative Titles

Full title

Clearance of Driver Mutations after Transplantation for Myelofibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3153879153

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153879153

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2408941

How to access this item